Mark E Molitch Selected Research

Mark E Molitch Research Topics

Disease

15	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 09/2006
14	Neoplasms (Cancer) 09/2020 - 01/2003
13	Prolactinoma (Prolactinomas) 09/2020 - 10/2002
13	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020 - 02/2001
13	Hyperglycemia 11/2018 - 09/2006
12	Type 2 Diabetes Mellitus (MODY) 01/2022 - 07/2008
12	Hyperprolactinemia 01/2021 - 10/2002
11	Acromegaly 01/2022 - 08/2003
10	Albuminuria 01/2021 - 12/2002
9	Hypertension (High Blood Pressure) 02/2017 - 08/2003
8	Chronic Renal Insufficiency 01/2021 - 10/2014
7	Infections 01/2021 - 01/2010
7	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020 - 02/2001
7	Pituitary Neoplasms (Pituitary Adenoma) 01/2019 - 08/2003
6	Cushing Syndrome 10/2022 - 08/2003
5	Kidney Diseases (Kidney Disease) 01/2021 - 12/2012
5	Pituitary ACTH Hypersecretion 01/2021 - 08/2003
5	Hypopituitarism (Sheehan's Syndrome) 01/2014 - 01/2007
4	Adrenal Insufficiency (Adrenal Gland Hypofunction) 10/2022 - 06/2015
4	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2021 - 10/2002
4	Weight Loss (Weight Reduction) 12/2018 - 07/2003
4	Diabetes Mellitus 01/2018 - 09/2008
4	Adenoma (Adenomas) 02/2017 - 08/2003
4	Fatigue 02/2016 - 06/2012
4	Weight Gain 06/2014 - 09/2008
3	Galactorrhea 01/2021 - 06/2012
3	Inflammation (Inflammations) 01/2018 - 01/2007
3	Anemia 01/2018 - 01/2014
3	Infertility (Sterility) 02/2017 - 01/2002
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 10/2014
3	Atherosclerosis 01/2017 - 08/2013
3	End Stage Liver Disease 09/2016 - 01/2010
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2015 - 12/2002
3	Insulin Resistance 10/2014 - 07/2008
3	Dyslipidemias (Dyslipidemia) 10/2014 - 09/2006
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2014 - 06/2009
2	Body Weight (Weight, Body) 10/2022 - 12/2018
2	Ketosis 01/2021 - 01/2021
2	Renal Insufficiency (Renal Failure) 01/2021 - 01/2021
2	Hyperthyroidism 02/2017 - 08/2003
2	Amenorrhea 02/2017 - 05/2011
2	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2017 - 08/2003
2	Hirsutism 04/2016 - 06/2015
2	Nausea 04/2016 - 06/2012
2	Spontaneous Abortion (Miscarriage) 05/2015 - 12/2011
2	Autoimmune Diseases (Autoimmune Disease) 01/2007 - 01/2007
1	Muscle Weakness 10/2022

Drug/Important Bio-Agent (IBA)

26	Insulin (Novolin)FDA Link 01/2022 - 11/2006
23	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 12/2002
16	Dopamine Agonists (Dopamine Agonist)IBA 01/2021 - 10/2002
13	ProlactinIBA 01/2021 - 08/2003
12	Testosterone (Sustanon)FDA Link 11/2018 - 10/2002
11	Bromocriptine (Parlodel)FDA LinkGeneric 02/2017 - 01/2002
11	Cabergoline FDA LinkGeneric 02/2017 - 10/2002
9	Hormones (Hormone)IBA 01/2021 - 08/2003
8	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2021 - 01/2004
8	AlbuminsIBA 03/2011 - 02/2001
7	Growth Hormone (Somatotropin)IBA 01/2022 - 08/2003
7	CreatinineIBA 01/2021 - 05/2010
6	Mifepristone (RU 486)FDA Link 10/2022 - 06/2012
5	lanreotide (Somatuline)FDA Link 01/2022 - 01/2008
5	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2021 - 08/2003
5	Hemoglobins (Hemoglobin)IBA 01/2018 - 05/2010
5	Blood Glucose (Blood Sugar)IBA 10/2014 - 09/2006
4	Antipsychotic Agents (Antipsychotics)IBA 09/2020 - 08/2005
4	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 02/2017 - 08/2003
4	Metformin (Glucophage)FDA LinkGeneric 01/2017 - 07/2003
3	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 10/2022 - 06/2012
3	Insulin-Like Growth Factor I (IGF-1)IBA 01/2022 - 06/2010
3	Estrogens (Estrogen)FDA Link 09/2020 - 08/2005
3	LipidsIBA 01/2018 - 01/2006
3	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 02/2017 - 06/2010
3	Antihypertensive Agents (Antihypertensives)IBA 09/2008 - 08/2005
2	Dexamethasone (Maxidex)FDA LinkGeneric 10/2022 - 01/2021
2	Octreotide (Sandostatin)FDA LinkGeneric 01/2022 - 06/2010
2	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021 - 01/2021
2	Metyrapone FDA Link 01/2021 - 06/2015
2	Uric Acid (Urate)IBA 01/2020 - 01/2019
2	Allopurinol (Remid)FDA LinkGeneric 01/2020 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2017
2	GonadotropinsIBA 01/2018 - 01/2003
2	Insulin-Like PeptidesIBA 02/2017 - 01/2014
2	Insulin Glargine (Lantus)FDA Link 09/2016 - 11/2006
2	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 10/2014 - 10/2014
2	Vitamin D FDA LinkGeneric 08/2013 - 12/2012
2	Triglycerides (Triacylglycerol)IBA 03/2011 - 05/2010
2	LDL CholesterolIBA 03/2011 - 09/2006
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 03/2011 - 07/2010
2	Hemoglobin AIBA 09/2008 - 02/2001
2	Antidepressive Agents (Antidepressants)IBA 01/2008 - 08/2005
2	Pergolide (Permax)FDA Link 01/2005 - 01/2003
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2022

Therapy/Procedure

30	Therapeutics 01/2022 - 02/2001
13	Glycemic Control 12/2018 - 12/2002
5	Liver Transplantation 11/2018 - 07/2011
4	Transplantation 11/2018 - 07/2011
3	Radiotherapy 12/2016 - 08/2006
3	Drug Therapy (Chemotherapy) 10/2014 - 06/2011
3	Estrogen Replacement Therapy 05/2014 - 01/2003
2	Length of Stay 10/2018 - 09/2016